IRB Barcelona opens new laboratory focused on targeted protein degradation as a therapeutic tool Blog Post

Scientist Cristina Mayor-Ruiz joins the Institute for Research in Biomedicine (IRB Barcelona) to lead the new Targeted Protein Degradation and Drug Discovery Lab. Along with the addition of this group, the Institute, based in the Barcelona Science Park, is also launching a Drug Screening Unit, thereby reflecting a clear commitment to speeding up the transfer of basic research to clinical practice.

 

Arian International and the CEI International Affairs will launch the 2nd edition of the European Proposal Writing Course Blog Post

Arian Internacional -a company associated with Barcelona Science Park (PCB) and accredited by ICEX Spain Export and Investment– and the CEI International Affairs –affliated Center to the University of Barcelona in the diplomacy and international relations field– launch the 2nd edition of the European Proposal Writing Course, offering an Expert title, issued by the University of Barcelona (UB).

 

Great success of the 13th IBEC Symposium “Bioengineering for Future & Precision Medicine” Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, organized from the 27th to the 28th October its 13th Symposium. The event, that this year took place for the first time online, was focused on “Bioengineering for Future & Precision Medicine”. With more than 400 registered attendees, the event also counted with contributions from top international speakers.

 

A project led by IBMB-CSIC tests molecules that stop the cytokine storm caused by SARS-CoV-2 Blog Post

A team of researchers led by Timothy Thomson’s group from the Barcelona Institute of Molecular Biology (IBMB-CSIC), based at the Barcelona Science Park, has developed a platform that allows to see in real-time if a drug inhibits the immune cellular response caused by SARS-CoV-2 infection. The project has the advantage that all the molecules being tested are previously known drugs and compounds that are used for other clinical indications. This would expedite the necessary procedures to propose, in due course, the use in patients with COVID-19.

 

Researchers reveal the evolutionary events leading to the creation of eukaryotic cells Blog Post

A collaborative study between the groups of Toni Gabaldón, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) and Berend Snel at the University of Utrecht, has reconstructed the evolutionary events leading to the creation of eukaryotic cells, the precursors to virtually all life you can see with the naked eye. The work, published in Nature Ecology & Evolution, reveals that The evolutionary timeline from simple bacterial cells to complex eukaryotic cells progressed differently than previously thought.

 

Dades i indicadors Page

Portal de Transparència Active advertising Institutional information Economic, budgetary and asset management Contracts and agreements List of companies to which the foundation subcontracts services Grants awarded Staff Content update procedure...